Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer.

about

In Vitro Assessment of Anthelmintic Activities of Rauwolfia vomitoria (Apocynaceae) Stem Bark and Roots against Parasitic Stages of Schistosoma mansoni and Cytotoxic Study.Inhibition of pancreatic cancer stem cells by Rauwolfia vomitoria extract

P2860

Q37699875-1351EDFF-0FD4-4AEF-AD4B-2351E94D4301 Q57074008-0E4787D1-E07C-4811-ABB4-32F74C10186E

P2860

Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer.

Item

http://www.wikidata.org/entity/Q39001305

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Antitumor Activities of Rauwol ...... cts Against Pancreatic Cancer.

@en

Antitumor Activities of Rauwol ...... cts Against Pancreatic Cancer.

@nl

type

Item

label

Antitumor Activities of Rauwol ...... cts Against Pancreatic Cancer.

@en

Antitumor Activities of Rauwol ...... cts Against Pancreatic Cancer.

@nl

prefLabel

Antitumor Activities of Rauwol ...... cts Against Pancreatic Cancer.

@en

Antitumor Activities of Rauwol ...... cts Against Pancreatic Cancer.

@nl

P1476

Antitumor Activities of Rauwol ...... cts Against Pancreatic Cancer.

@en

P2093

Jun Yu

http://www.w3.org/2001/XMLSchema#string

Qi Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Advances in using PARP inhibitors to treat cancer

JNK-induced apoptosis, compensatory growth, and cancer stem cells

Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Pancreatic cancer

Evolution of systemic therapy for advanced pancreatic cancer.

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).

P304

217-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1534735414532010

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261882862

http://www.w3.org/2001/XMLSchema#string

P698

24764328

http://www.w3.org/2001/XMLSchema#string

Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer.

about

P2860

P2860

Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Gemcitabine Effects Against Pancreatic Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698